To answer this question, we first developed a PDX library of BRAF-mutant metastatic melanoma and observed a correlation between VAF and increased stability of driver mutations across the patient tumour, corresponding PDX and subsequent generations of PDXs for multiple genes (e.g., BRAF, KDR, TP53 and PTEN). This evidence concerns the gene TP53 and neoplasm.